TRON Seminars in Translational Oncology: Dr. Evan Newell

Mainz, August 2017 – On Aug. 24th Dr. Evan Newell from the Singapore Immunology Network (SIgN) in Singapore is visiting Mainz in the context of the Seminars in Translational Oncology (SITO). You are cordially invited to his talk at 5 pm s.t. in Building 708 of the University Medicine Mainz.

The title of his talk is: High-dimensional profiling of human antigen-specific T cells: Asking T cells what they ‘see’ in cancer.

Dr. Evan Newell is Principal Investigator at SIgN and the Agency for Science, Technology and Research (A*STAR) in Singapore. After receiving his PhD in at the Department of Physiology at the University of Toronto, Dr. Newell continued as a Post-Doc at Stanford University in California. There, in the lab of Dr. Mark Davis in the Department of Microbiology and Immunology, he worked on the structural and biophysical basis for T-cell receptor antigen recognition and phenotypic profiling of antigen-specific T cells. He now leads a research lab with the focus to apply and develop new methods that take advantage of single-cell mass spectrometry (a.k.a., mass cytometry or Cytometry by Time-Of-Flight, CyTOF) for the identification and characterization of antigen-specific T cells. He intends to use that information to identify novel correlates of clinical outcomes for a variety of diseases.

Please find more information on Prof. Newell’s work on his website: https://www.a-star.edu.sg/sign/research/principal-investigators/tid/4/newell-evan.aspx